cp 65,526 has been researched along with tacrolimus in 1 studies
| Studies (cp 65,526) | Trials (cp 65,526) | Recent Studies (post-2010) (cp 65,526) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
|---|---|---|---|---|---|
| 65 | 1 | 5 | 17,757 | 2,319 | 6,661 |
| Protein | Taxonomy | cp 65,526 (IC50) | tacrolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.18 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arceci, RJ; Bierer, BE; Stieglitz, K | 1 |
1 other study(ies) available for cp 65,526 and tacrolimus
| Article | Year |
|---|---|
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Daunorubicin; Drug Resistance; Drug Synergism; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Phenotype; Polyenes; Prazosin; Sirolimus; Tacrolimus; Tumor Cells, Cultured | 1992 |